Multidrug Resistant Gram-negative Pathogen Infections in High Risk Neonates in the Northeast of Mexico (InfGNMDR-Neo)
Infecciones Por patógenos Gramnegativos Con Multirresistencia a Drogas en Neonatos de Alto Riesgo en el Noreste de México
Sponsor: Instituto Tecnologico y de Estudios Superiores de Monterey
A observational or N/A phase clinical study on Infant Newborn Disease, this trial is completed. The trial is conducted by Instituto Tecnologico y de Estudios Superiores de Monterey and has accumulated 7 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2023 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Dec 2021 — Apr 2023 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Apr 2021 — Sep 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Instituto Tecnologico y de Estudios Superiores de Monterey
For direct contact, visit the study record on ClinicalTrials.gov .